1AI 16.7% 0.7¢ algorae pharmaceuticals limited

Questions for my statistically challenged benefit.Q1 Once the 6...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 121 Posts.
    lightbulb Created with Sketch. 100
    Questions for my statistically challenged benefit.

    Q1 Once the 6 mth trial became unblinded, did the placebo effect cease to be measured?

    Q2. Why are new patients needed for control? Isn’t the entire population of PD pts or a random sample therefrom a control?

    Q3. What about the nocebo effect? Pts who are informed of having had placebo are still subject to the nocebo effect, ie I don’t care it was a sham, I feel a benefit and will continue to release dopamine as a result.

    Q4. How can any result be deemed significant one day (at 18mths) and not the next? Can the null hypothesis be so elastic?

    Thx in advance for anyone willing to waste their time as I’ve just done.
    u




 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.001(16.7%)
Mkt cap ! $11.81M
Open High Low Value Volume
0.6¢ 0.7¢ 0.6¢ $746 107.7K

Buyers (Bids)

No. Vol. Price($)
17 5265293 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 90900 1
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.